Last edition
News about "biotech stock offering"
Forte Biosciences Announces Pricing of USD 150 Million Public Offering
Forte Biosciences announces pricing of its USD 150 million public offering, with expected gross proceeds of USD 150 million before underwriting discounts, commissions, and offering expenses.
Biotech Stock Offering | 10/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members